Analgesics (Pharmacies) - Morocco

Revenue in the Analgesics market is projected to reach US$119.10m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 5.76%, resulting in a market volume of US$157.60m by 2029.
In global comparison, most revenue will be generated China (US$5.03bn in 2024).
In relation to total population figures, per person revenues of US$3.12 are generated in 2024.

Definition:
The Analgesics market encompasses non-prescription natural and synthetic non-opioid analgesics sold through pharmacies. These include well-known products such as Paracetamol, Ibuprofen, Aspirin, Diclofenac, and various pain-relieving preparations. The market's scope varies with national legislation concerning opioid analgesics, with legal opioids being incorporated based on respective state regulations. In countries like Germany, Austria, and Switzerland, opioid analgesics are included if they comply with narcotics law limitations and do not necessitate a prescription. The analgesics are presented in forms like pills, capsules, gels, and ointments. However, the market excludes prescription medications (e.g., morphine), anesthetics, and homeopathic remedies. Notable top-selling painkillers encompass Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol, and ASS. This market exclusively covers product sales through pharmacies.

Additional information:
The Analgesics market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics (Pharmacies) market in Morocco is experiencing steady growth due to several factors. Customer preferences for over-the-counter pain relief medication, along with local special circumstances and underlying macroeconomic factors, are driving the development of the market. Customer preferences in Morocco favor convenient and accessible pain relief options. Many individuals prefer to purchase analgesics from pharmacies, where they can receive professional advice and guidance. This preference for pharmacies as a primary distribution channel for analgesics has contributed to the growth of the market. Additionally, customers in Morocco tend to prefer familiar and trusted brands when it comes to purchasing medication, which has further fueled the demand for analgesics in pharmacies. Trends in the market indicate a shift towards natural and herbal pain relief options. Moroccan consumers are increasingly seeking products that are perceived as being more natural and holistic. This trend aligns with the global movement towards wellness and self-care, as individuals are becoming more conscious of the ingredients and potential side effects of pharmaceutical products. As a result, pharmacies in Morocco are expanding their offerings to include a wider range of natural and herbal analgesics to cater to this growing demand. Local special circumstances in Morocco, such as the prevalence of traditional medicine and cultural practices, also impact the development of the analgesics market. Traditional herbal remedies have long been used in Moroccan culture to alleviate pain and discomfort. This cultural preference for natural remedies has influenced the market, as individuals may choose to explore traditional options before turning to pharmaceutical analgesics. Pharmacies in Morocco have recognized this preference and have started incorporating traditional herbal remedies into their product offerings, further driving the growth of the market. Underlying macroeconomic factors, such as population growth and increasing disposable incomes, are contributing to the development of the analgesics market in Morocco. The country's population is growing, resulting in a larger consumer base for analgesics. Additionally, rising disposable incomes have allowed individuals to spend more on healthcare and wellness products, including analgesics. As a result, the demand for analgesics in pharmacies has increased, driving the growth of the market. In conclusion, the Analgesics (Pharmacies) market in Morocco is developing due to customer preferences for convenient and accessible pain relief options, the trend towards natural and herbal remedies, local special circumstances related to traditional medicine, and underlying macroeconomic factors such as population growth and increasing disposable incomes. These factors have contributed to the steady growth of the market and are expected to continue driving its development in the future.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.